Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy
- Conditions
- Open Angle Glaucoma
- Interventions
- Device: Near to infrared light retinal stimulationDevice: Green light stimulation
- Registration Number
- NCT00844389
- Lead Sponsor
- Universidad de Valparaiso
- Brief Summary
The purpose of the study is to evaluate if near-to-infrared light stimulation can improve retinal ganglion cell function in glaucomatous patients.
- Detailed Description
Ganglion cell dysfunction in glaucomatous optic neuropathy has been ascribed to ganglion cell electrophysiological inactivation and to apoptotic cell death. Near-to-infrared light stimulation has been used to induce mitochondrial activation and to prevent apoptotic death through mitochondrial cytochrome oxidase c stimulation. Near-to-infrared light stimulation might be useful to induce ganglion cell activation and inhibit apoptotic cell death.
We propose that near-to-infrared light stimulation can be used as an adjuvant treatment combined with ocular hypotensive treatment in glaucomatous patients.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 40
- Clinical diagnose of Ocular Hypertension (cup to disk ratio 0,6 or less, normal Humphrey 24-2 visual field with aplanatic IOP over 21 mmHg) or Mild Glaucoma (cup to disk ratio 0,6 to 0,8, characteristic Humphrey 24-2 visual field defect PSD between 3 and 6 dB).
- Visual acuity 20/40 or better
- Diabetic retinopathy, Multiple Sclerosis, Parkinson disease
- Refractive error of 3 diopters or more
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description NIR light Near to infrared light retinal stimulation Group of patients stimulated with near to infrared light daily stimulation Green light Green light stimulation Group of patients stimulated with green light.
- Primary Outcome Measures
Name Time Method Pattern electroretinogram response Every two weeks for 4 months
- Secondary Outcome Measures
Name Time Method OCT ganglion cell layer average thickness, Visual Field defects Every month for four months
Trial Locations
- Locations (1)
Servicio de Oftalmología Hospital Van Buren
🇨🇱Valparaiso, Chile